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Diagnostic tests
The diagnosis of recurrent deep venous thrombosis
Harry Gibbs, Associate Professor of Medicine, University of Queensland, and Director,  
Department of Vascular Medicine, Princess Alexandra Hospital, Brisbane
Summary
Duplex ultrasound is the preferred investigation 
for the diagnosis of initial and recurrent deep 
venous thrombosis. The contralateral leg should 
be scanned when thrombosis is diagnosed as 
it is bilateral in 30% of cases. At the completion 
of anticoagulant therapy a venous duplex 
scan should be performed to establish a new 
baseline. Recurrent deep venous thrombosis can 
subsequently be diagnosed if there is a 5 cm 
increase in the extent of residual thrombus or an 
increase in the compressed thrombus diameter 
of more than 2 mm. If there is any doubt about 
the presence of a recurrent thrombosis serial 
ultrasound should be used.
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Introduction
Deep venous thrombosis (DVT) is a common cause of mortality 
and morbidity with an annual incidence of about 1/1000. It 
may be complicated by pulmonary embolism and the post-
thrombotic syndrome. 
About 30% of patients with a proximal thrombosis (involving 
the popliteal or more proximal veins) who do not receive 
anticoagulant therapy will develop symptomatic pulmonary 
embolism within 30 days. Symptomatic pulmonary embolism is 
dangerous as 25% of cases are fatal. Post-thrombotic syndrome 
is characterised by pain and swelling of the affected limb and 
occurs in 50–60% of patients with symptomatic DVT. Graduated 
compression stockings relieve the symptoms in many cases. 
However, about 10% of patients will have symptoms that impair 
their quality of life in spite of compression stockings and about 
4% will develop venous ulcers.
Anticoagulation is highly effective in preventing death from 
pulmonary embolism in patients with DVT. It is indicated for all 
proximal DVTs and for most cases of symptomatic distal DVT. 
Therapy begins with low molecular weight or unfractionated 
heparin followed by long-term treatment with a vitamin K 
antagonist such as warfarin. 
The problem of recurrence
Anticoagulation is highly effective in preventing recurrent 
DVT, but is associated with a risk of major bleeding of about 
3% per year. It is therefore usual to stop anticoagulation six 
months after a first episode of DVT.   Thereafter, DVT is often a 
chronic and relapsing condition with recurrences in about 30% 
of patients within eight years. Recurrent DVT is important as 
it increases the likelihood of post-thrombotic syndrome and is 
associated with pulmonary embolism.
Risk factors for recurrence
Several risk factors predict the recurrence of DVT. The most 
powerful of these is whether or not the first thrombosis was 
provoked by a transient risk factor such as surgery. The annual 
recurrence rate is 1–3% in patients whose DVTs were provoked 
by transient risk factors, compared with 8% in patients whose 
DVTs were unprovoked. Certain clinical, laboratory and imaging 
factors are also important predictors of recurrence. 
Clinical predictors of recurrence include male gender, 
increasing age and body mass index, active malignancy and 
neurological disease with paresis of the extremities. Laboratory 
abnormalities that predict recurrence include thrombophilias 
such as antiphospholipid antibodies, deficiency of protein C, S 
or antithrombin and the Factor V Leiden or prothrombin gene 
mutations. The commonest of these abnormalities are the Factor V 
Leiden and prothrombin gene mutations but these have only a 
very weak influence on recurrence. Extensive residual thrombus 
on imaging studies is also a risk for recurrence. 
At present, indefinite anticoagulation is usually recommended 
after an otherwise unprovoked first DVT in patients with active 
malignancy or with certain rare thrombophilias (including 
the presence of antiphospholipid antibodies, homozygosity 
for the Factor V Leiden and prothrombin gene mutations and 
multiple thrombophilias). These conditions have particularly 
high recurrence rates. Although other patients usually stop after 
six months, studies of the role of longer-term anticoagulation in 
other sub-groups are ongoing.
Diagnosis of first DVT
The clinical diagnosis of DVT is inaccurate as other clinical 
conditions may mimic it. Anticoagulant therapy is potentially 
dangerous as it causes major bleeding in about 5% of cases 
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of acute DVT within the first three months and 3% per year 
thereafter. Objective testing is thus required to establish or 
refute the diagnosis of DVT before treatment. Anticoagulation 
should not be commenced for suspected DVT without 
confirmatory objective testing, except in extreme circumstances.
Imaging
Contrast venography was regarded as the gold standard for the 
diagnosis of DVT, but requires intravenous contrast media and 
exposes the patient to ionizing radiation. As duplex ultrasound 
is readily available, safe and accurate it has essentially replaced 
venography as the first and definitive diagnostic test. For 
proximal DVT the sensitivity and specificity of duplex ultrasound 
are greater than 90%. 
Duplex ultrasound is the first-line investigation for the vast 
majority of patients with suspected DVT. 
The diagnostic criterion for DVT is 
incompressibility of the vein when 
applying gentle pressure with the overlying 
ultrasound transducer. Additional findings 
with DVT include the presence of echogenic 
material within the vein lumen, incomplete 
filling of the vein with colour Doppler, and lack of the usual 
variation of the venous flow with respiration. 
Duplex ultrasound is operator dependent. Ideally the scan 
should be performed by a sonographer accredited by the 
Australasian Sonographer Accreditation Registry who is 
supervised by a clinician experienced in reporting vascular 
ultrasound. A comprehensive duplex ultrasound should 
examine the veins continuously from the inguinal ligament 
to the ankle. This is effective for excluding DVT so it is safe to 
withhold anticoagulation if the scan is negative. A positive result 
is adequately specific for DVT to indicate anticoagulant therapy.
Duplex ultrasound of the contralateral leg should be performed 
in all confirmed cases as DVT is bilateral in about 30% of 
patients. This helps avoid diagnostic confusion at a later stage if 
symptoms then develop in the other leg.
Computerised tomography and magnetic resonance 
venography are expensive. They offer no tangible advantage 
over duplex ultrasound.
Laboratory tests
D-dimer is a thrombus breakdown product that is almost 
always detected in the blood of patients with DVT. Sensitive 
d-dimer assays (using whole blood or ELISA methods) have 
been used to exclude DVT and reduce the need for imaging. 
Patients who have a low probability of DVT, as assessed by a 
standardised clinical scoring system such as the Wells score1 
(Table 1), and who also have a negative d-dimer test can safely 
have anticoagulation withheld. D-dimer is not able to exclude 
DVT in patients with a high Wells score so those patients require 
diagnostic imaging. 
There are many causes of a positive d-dimer including infection, 
malignancy, acute coronary syndromes, recent surgery, 
pregnancy and severe peripheral artery disease. A positive  
d-dimer is therefore of no diagnostic value. Overall, about 
30% of patients in whom DVT is initially suspected will have 
it excluded by a low Wells score and negative d-dimer testing. 
In practice, however, d-dimer testing is often performed 
inappropriately and without reference to the Wells score. 
For these reasons and because duplex ultrasound is safe, 
inexpensive and usually accessible, I favour it over d-dimer as 
the initial test in all patients with suspected DVT.
Diagnosis of recurrent DVT
Duplex ultrasound is the first-line investigation but the diagnosis 
of recurrent DVT can be difficult. The diagnostic criteria for 
recurrent DVT include incompressibility of 
a previously normal segment of vein or 
an increase in the compressed diameter 
of a segment of vein with previously 
documented thrombus. Both of these 
criteria require knowledge of the extent 
of residual thrombus that is present at 
the completion of anticoagulant therapy. It is therefore critical 
to perform a comprehensive duplex ultrasound scan when 
anticoagulation is ceased, to establish a new baseline against 
which further scans can be compared. The extent of residual 
thrombus should be recorded by reference to anatomical 
landmarks such as the upper border of the patella and the 
Table 1 
Wells score for clinical assessment of deep 
venous thrombosis (DVT) 1
Clinical feature Score
Active cancer 1
Paralysis, paresis or plaster immobilisation of  
the lower extremities 1
Bedridden for three days or major surgery,  
within four weeks 1
Localised tenderness along the deep venous  
system 1
Entire leg swollen 1
Calf diameter more than 3 cm larger on the  
symptomatic side 1
Pitting oedema greater on symptomatic side 1
Collateral nonvaricose superficial veins  1
Alternative diagnosis more probable than DVT –2
Probability of DVT:
 low  0
 moderate 1 or 2
 high 3 or more
Perform a comprehensive 
duplex ultrasound scan 
when anticoagulation  
is ceased
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saphenofemoral junction. For example, residual thrombus 
might be reported to extend from 5 cm below the upper border 
of the patella to 3 cm below the saphenofemoral junction. 
The compressed diameter of the vein should also be recorded 
at a number of points. This detailed information is required 
to interpret the results of subsequent scans and should be 
provided in the ultrasound report. A detailed diagram of the 
extent of residual DVT provides a rapid visual assessment of  
the required information and is particularly useful for 
subsequent comparison. 
A recent study has questioned the reproducibility of duplex 
ultrasound examinations and has suggested that a change of 
thrombus length of more than 9 cm is required to accurately 
diagnose recurrent DVT.2 This observation has not been tested 
in clinical outcome studies and requires replication. Currently, 
it is my practice to diagnose a recurrence if there is an increase 
in the length of thrombus of more than 5 cm in a duplex 
ultrasound scan performed by an experienced sonographer. 
An increase in the diameter of the vein by more than 2 mm 
when compressed by the ultrasound transducer also suggests 
recurrence. Finally, acute DVT tends to have a less echogenic 
appearance than chronic thrombus although this observation is 
subjective and has not been studied in comparative or outcome 
trials. If there is any doubt as to whether there is recurrent DVT 
then I perform two more scans over the next two weeks. If there 
is no change in these, then I withhold anticoagulation and only 
arrange further investigations if there is a significant clinical 
change. As duplex ultrasound is safe and inexpensive, I have a 
low threshold to undertake this surveillance program. 
Venography may be difficult to interpret in recurrent DVT. 
Computerised tomography and magnetic resonance 
venography have no established role.
A negative d-dimer may be of value in excluding recurrent DVT, 
but is less well-tested than for a first thrombosis. A positive 
d-dimer test neither confirms nor refutes the diagnosis of 
recurrent DVT, but necessitates further imaging investigations.
Additional tests
If the patient was thoroughly investigated at the time of their 
first deep venous thrombosis, there is no need to repeat all 
the specialist tests. The need for additional tests is guided by 
the history, examination and basic investigations. If the platelet 
count is persistently elevated, a myeloproliferative disorder may 
need to be excluded. A recurrent thrombosis that occurs during 
anticoagulation could be related to an undetected malignancy.
Conclusion
Recurrent deep venous thromboses can be difficult to diagnose. 
Identifying a recurrence is easier if the patient had a duplex 
ultrasound scan when they completed the anticoagulant therapy 
for their first thrombosis. Although its accuracy depends on the 
skill of the operator, duplex ultrasound is safe and relatively 
inexpensive. It should be the first-line investigation for recurrent 
deep venous thrombosis.
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Self-test questions
The following statements are either true or false  
(answers on page 55)
3. Magnetic resonance venography is now the gold standard 
test for the diagnosis of recurrent deep vein thrombosis.
4. After anticoagulant therapy for deep vein thrombosis is 
completed, the venous system should be assessed by 
duplex ultrasound.
